His primary areas of investigation include Genetics, Mutation, Genome, Molecular biology and Transcriptome. Genetics and Computational biology are frequently intertwined in his study. As part of his studies on Mutation, Ryan D. Morin often connects relevant areas like Cancer.
The various areas that Ryan D. Morin examines in his Molecular biology study include Germline mutation, Histone methyltransferase, Cancer research, Tyrosine kinase and Lymphoma. His Germline mutation research is multidisciplinary, relying on both Histone and EZH2. His Lymphoma study frequently draws connections to adjacent fields such as Somatic cell.
His primary areas of study are Cancer research, Lymphoma, Diffuse large B-cell lymphoma, Gene and Mutation. His Cancer research study incorporates themes from Exome sequencing, Cancer, Germinal center, B-cell lymphoma and EZH2. His work on Oncology expands to the thematically related Lymphoma.
The concepts of his Diffuse large B-cell lymphoma study are interwoven with issues in Tissue microarray, BCL6, Point mutation and Gene expression profiling. His Gene research is under the purview of Genetics. His Mutation research is multidisciplinary, incorporating perspectives in Histone methyltransferase, Mantle cell lymphoma, Somatic hypermutation, Pathology and Molecular biology.
His primary scientific interests are in Cancer research, Lymphoma, Diffuse large B-cell lymphoma, Gene and Mutation. His Cancer research research is multidisciplinary, incorporating elements of Cell culture, Somatic hypermutation, Germinal center, B-cell lymphoma and EZH2. His Lymphoma study integrates concerns from other disciplines, such as Phenotype, BCL6 and Oncology.
His studies deal with areas such as Cancer, Gene expression profiling, Molecular biology, Three prime untranslated region and Follicular lymphoma as well as Diffuse large B-cell lymphoma. The study incorporates disciplines such as Gene rearrangement and Double hit in addition to Molecular biology. Ryan D. Morin has researched Mutation in several fields, including Liquid biopsy, Mantle cell lymphoma, RNA-binding protein and Sudden cardiac death.
His main research concerns Cancer research, Lymphoma, Gene, Diffuse large B-cell lymphoma and BCL6. His study in Cancer research is interdisciplinary in nature, drawing from both Exome sequencing, Mutation, Somatic hypermutation, B-cell lymphoma and Colorectal cancer. His Mutation study combines topics in areas such as Vincristine, Arginine, Rituximab and CD20.
His research combines Phenotype and Lymphoma. His research on Gene focuses in particular on Genome. His work carried out in the field of BCL6 brings together such families of science as Molecular biology and Chromosomal translocation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Morin Rd;Johnson Na;Severson Tm;Mungall Aj.
Nature Genetics (2010)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D Morin;María Méndez-Lago;Andrew J Mungall;Rodrigo Goya.
Nature (2011)
Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells.
Ryan D Morin;Michael D O'Connor;Malachi Griffith;Florian Kuchenbauer.
Genome Research (2008)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah;Ryan D. Morin;Jaswinder Khattra;Leah Prentice.
Nature (2009)
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst.
Cancer Cell (2012)
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Daniel T Starczynowski;Florian Kuchenbauer;Bob Argiropoulos;Sandy Sung.
Nature Medicine (2010)
The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse
Michael P. McLeod;René L. Warren;William W. L. Hsiao;Naoto Araki.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P Shah;Martin Köbel;Janine Senz;Ryan D Morin.
The New England Journal of Medicine (2009)
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.
Damian B. Yap;Damian B. Yap;Justin Chu;Tobias Berg;Matthieu Schapira.
Blood (2011)
Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing.
Ryan D. Morin;Matthew Bainbridge;Anthony Fejes;Martin Hirst.
BioTechniques (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of British Columbia
BC Cancer Agency
University of British Columbia
Simon Fraser University
BC Cancer Agency
Memorial Sloan Kettering Cancer Center
University of British Columbia
Ascension Health
University of British Columbia
BC Cancer Agency
University of Salento
Nokia (United States)
University of California, San Diego
Aristotle University of Thessaloniki
Heidelberg University
Tokyo Institute of Technology
University of Ljubljana
Université Laval
National University of Singapore
University of Aveiro
Potsdam Institute for Climate Impact Research
University of Arizona
Arizona State University
Harvard University
Scuola Normale Superiore di Pisa